You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

M-spike negative

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial (Ficlatuzumab,

Not yet recruiting
  • Metastatic Head-and-neck Squamous-cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Ficlatuzumab
  • +2 more
  • (no location specified)
Sep 26, 2023

SARS-CoV-2 Infection Trial in South Africa (NVX-CoV2373)

Active, not recruiting
  • SARS-CoV-2 Infection
  • NVX-CoV2373
  • Westridge, Durban, South Africa
  • +6 more
May 25, 2022

TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Alkaline Glucosodiene Molecules
  • (no location specified)
Jul 14, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8

Terminated
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Bintrafusp Alfa
  • Eribulin Mesylate
  • Houston, Texas
  • +1 more
Oct 27, 2022

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Dalpiciclib+cetuximab)

Recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    the Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni
Feb 9, 2023

Breast Cancer Trial in Houston (Sacituzumab Govitecan, Pembrolizumab)

Not yet recruiting
  • Breast Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Dec 22, 2022

Edema, Erythema, Estrogen Receptor Negative Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)

Active, not recruiting
  • Edema
  • +8 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 23, 2023

Breast Cancer Trial in Guangzhou (BL-M02D1)

Recruiting
  • Breast Cancer
  • Bengbu, Anhui, China
  • +9 more
Jan 11, 2023

Infection, Drainage Trial in Chicago (Negative Pressure Wound Therapy (NPWT), Sterile Antimicrobial Dressings)

Recruiting
  • Infection, Drainage
  • Negative Pressure Wound Therapy (NPWT)
  • Sterile Antimicrobial Dressings
  • Chicago, Illinois
    Anne DeBenedetti
Oct 27, 2022

Triple Negative Breast Cancer Trial in Guangzhou (Gemcitabine and carboplatin plus antibiotic (moxifloxacin), Gemcitabine

Recruiting
  • Triple Negative Breast Cancer
  • Gemcitabine and carboplatin plus antibiotic (moxifloxacin)
  • Gemcitabine combined with carboplatin plus placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 6, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Houston (Control Group, TTI-101)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Houston, Texas
    M D Anderson Cancer Centerl
Apr 25, 2023

Necrotizing Fasciitis Trial in Augusta (Acellular Fish Skin Graft (AFS) and Negative Pressure Wound Therapy (NPWT), Acellular

Recruiting
  • Necrotizing Fasciitis
  • Acellular Fish Skin Graft (AFS) and Negative Pressure Wound Therapy (NPWT)
  • Acellular Human Cadaver (AHC) and Negative Pressure Wound Therapy (NPWT)
  • Augusta, Georgia
    Joseph M. Still Research Foundation
Oct 2, 2023

Wound, Ulcer, Burns Trial in Loma Linda (Negative pressure wound therapy coupled with instillation, Standard Negative Pressure

Recruiting
  • Wound
  • +2 more
  • Negative pressure wound therapy coupled with instillation
  • Standard Negative Pressure Wound Therapy
  • Loma Linda, California
    Loma Linda University
Apr 20, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 2, 2022

Myeloproliferative Tumor Trial in Toronto (Azacitidine, Venetoclax)

Not yet recruiting
  • Myeloproliferative Neoplasm
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 12, 2022

Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)

Recruiting
  • Triple Negative Breast Cancer
  • +5 more
  • Manchester, Greater Manchester, United Kingdom
  • +6 more
Jan 5, 2023

Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in United States (procedure, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +3 more
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • +3 more
  • Houston, Texas
  • +5 more
Feb 11, 2022

Breast Cancer Trial in Canada (CFI-402257, Paclitaxel)

Active, not recruiting
  • Breast Cancer
  • Vancouver, British Columbia, Canada
  • +3 more
Jan 30, 2023

High Grade Serous Carcinoma, Triple Negative Breast Cancer, Ovarian Cancer Trial (Olaparib tablet, Navitoclax)

Recruiting
  • High Grade Serous Carcinoma
  • +2 more
  • Toronto, Ontario, Canada
  • +2 more
Nov 28, 2022

Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8

Active, not recruiting
  • Anatomic Stage IIB Breast Cancer AJCC v8
  • +19 more
  • Gilbert, Arizona
  • +4 more
Dec 6, 2022

Among Talazoparib-Treated HER2-Negative mBC With gBRCA1/2m

Completed
  • Metastatic Breast Cancer
  • Breast Neoplasms
  • New York, New York
    Pfizer Inc.
Aug 5, 2022

Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, Endometrial Cancer Trial in Oklahoma City, Houston (AO-252)

Recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Oklahoma City, Oklahoma
  • +1 more
Nov 13, 2023

Sarcoma, Cancer, Infectious Disease Trial in Charleston (Prevana Dressing, Standard Dry Gauze Dressing)

Recruiting
  • Sarcoma
  • +2 more
  • Prevana Dressing
  • Standard Dry Gauze Dressing
  • Charleston, South Carolina
    Medical University of South Carolina
Apr 28, 2022

Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

Not yet recruiting
  • Breast Cancer
  • Marseille, France
    Institut Paoli Calmettes
Aug 9, 2023

HIV Trial in Oxford (ChAdOx1.tHIVconsv1 (C1), MVA.tHIVconsv3 (M3), MVA.tHIVconsv4 (M4))

Completed
  • HIV
  • ChAdOx1.tHIVconsv1 (C1)
  • +2 more
  • Oxford, United Kingdom
    Centre for Clinical Vaccinology and Tropical Medicine, Churchill
Aug 10, 2022